HB66 Alabama 2012 Session

Summary

Primary Sponsor

K.L. Brown

Republican

Session

Regular Session 2012

Title

Alabama Medical Marijuana Patients Rights Act, authorizing medical use of marijuana for certain qualifying patients.

Summary

HB66 would authorize medical marijuana use for Alabama patients with serious medical conditions and create a regulated system of patients, caregivers, providers, and labs to manage its use and distribution.

What This Bill Does

The bill allows physician-diagnosed patients with serious conditions to possess and use cannabis for medical purposes with an ID card. It creates nonprofit medical cannabis dispensing centers, delivery services, cultivators, product manufacturers, and laboratories to grow, distribute, test, and supply medical cannabis. It sets possession and cultivation limits (eight ounces per patient and up to 12 plants per patient) and allows collective cultivation under defined relationships. It provides legal protections for patients and designated caregivers, outlines employer and safety rules, and allows visiting patients from other states to participate under the act.

Who It Affects

• Qualified patients diagnosed with a serious medical condition who can obtain an identification card and possess cannabis under the program.
• Designated caregivers designated by patients to assist with cultivation, procurement, and administration, who also obtain identification cards.
• Physicians who diagnose and recommend medical cannabis, who are protected from penalty for making such recommendations.
• Medical cannabis dispensing centers, delivery services, cultivators, product manufacturers, and medical cannabis laboratories (nonprofit entities) that participate in the program.
• State and local law enforcement and county health departments responsible for issuing and verifying ID cards and enforcing program rules.
• Municipalities and counties that regulate dispensing centers, delivery services, and product labeling, with authority to implement local regulations while not banning the program.
• Employers and employees, with protections against certain forms of discrimination related to medical cannabis use, subject to safety-sensitive job exceptions.

Key Provisions

• Section 2 defines key terms: cannabis plant, designated caregiver, department, medical cannabis cultivator, medical cannabis dispensing center, medical cannabis delivery service, medical cannabis laboratory, medical cannabis product manufacturer, qualified patient, and serious medical condition.
• Section 3 creates exemptions from certain marijuana possession and cultivation laws for qualified patients and designated caregivers with physician approval, and protects physicians who recommend cannabis.
• Section 4 sets limits on possession and cultivation (eight ounces of dried cannabis and up to 12 plants per patient) and authorizes cooperative cultivation under defined relationships; law enforcement must recognize department-issued IDs.
• Section 5 establishes the identification card program, including a 24-hour verification system, county duties to process applications, and ID card issuance with a two-year validity and associated fees.
• Section 6-7-8 address workplace and civil protections: no required accommodation at work for medical cannabis; no automatic discrimination for qualified patients/caregivers except in safety-sensitive jobs; civil remedies for violations; driving rules regarding cannabis use and metabolites.
• Section 9 clarifies that certain uses of cannabis (e.g., positive tests, being a patient or caregiver, exercising rights) are not treated as habitual illegal substance use.
• Section 10 grants visiting qualified patients the same rights as resident qualified patients.
• Section 11 outlines law enforcement seizure procedures and the return of usable cannabis and related property if the person is found to be complying with the act.
• Section 12 recognizes medical cannabis use as a legitimate medical treatment for care decisions, equal to other physician-directed medications.
• Section 13 allows collective or cooperative cultivation among patients and designated caregivers, including cost sharing and occupational roles within the collective.
• Section 14 imposes fees for patient IDs and growers licenses and establishes class-based licensing for dispensaries, suppliers, and edible cannabis operations.
• Section 15-18 authorize and guide local regulation of dispensing centers, delivery services, and manufacturing/labeling of products; testing remains voluntary; local laws may align with the act.
• Section 19 creates three classes of medical cannabis cultivators with different registration rules and annual renewals, under the Department of Agriculture and Industries, including rules for inspections and security.
• Section 20 authorizes the creation of medical cannabis laboratories for testing any cannabis form to ensure safety and proper composition.
• Section 21 tasks the Alabama State Board of Pharmacy with classifying cannabis as a Schedule III, IV, or V substance within 180 days.
• Section 22 sets the act’s effective date as the first day of the third month after passage and approval.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Health